Work

A Dual CYP17A1/HDAC6 Inhibitor for Targeted Prostate Cancer Therapy

Year: 2025

Type: article

Source: The FASEB Journal

DOI: 10.1096/fj.202502614r

Authors: Hoang Yen Tran, Chien‐Liang Lin, Hong‐Yi Lin, Chih‐Jie Shen, Ram Sharma, Jing‐Ping Liou, Tsung‐I Hsu

Institutions: Can Tho University of Medicine and Pharmacy, Taipei Medical University, Chi Mei Medical Center, Taiwan Brain Disease Foundation, National Health Research Institutes

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Science and Technology Council, Chi Mei Medical Center

Awards: G1341255650, Targeting Glioblastoma Resilience: Role of Progesterone in Enhancing Chemotherapeutic and Immunotherapeutic Responses through Modulating Protein Sialylation, To Boost Nk Cell Therapy Targeting Glioblastoma by Tuning Steroid Synthesis to Allopregnanolone and Reprogramming Fatty Acid Metabolism in Tumor Cells, G7742772761

OpenAlex ID: W4415294062

FWCI:

Cites: 32

Cited by:

Related to: